4996 — Kumiai Chemical Industry Co Balance Sheet
0.000.00%
- ¥85bn
- ¥130bn
- ¥161bn
- 54
- 88
- 37
- 67
Annual balance sheet for Kumiai Chemical Industry Co, fiscal year end - October 31st, JPY millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 19,390 | 20,055 | 22,300 | 27,080 | 27,404 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 27,534 | 33,688 | 49,595 | 35,726 | 45,498 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 90,803 | 105,203 | 132,836 | 141,995 | 178,355 |
| Net Property, Plant And Equipment | 34,029 | 37,281 | 43,145 | 47,587 | 52,205 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 154,857 | 169,172 | 204,604 | 226,939 | 275,474 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 33,820 | 35,630 | 62,868 | 71,688 | 96,021 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 56,443 | 65,283 | 89,136 | 93,913 | 129,557 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 98,414 | 103,889 | 115,468 | 133,026 | 145,917 |
| Total Liabilities & Shareholders' Equity | 154,857 | 169,172 | 204,604 | 226,939 | 275,474 |
| Total Common Shares Outstanding |